ask="0.9399"
ask_size="900"
average_daily_volume="354352"
bid="0.7021"
bid_size="2000"
book_value="0.6070"
change="-0.0141"
change_from_200_day_moving_average="-0.5170"
change_from_50_day_moving_average="-0.0147"
change_from_52_week_high="-3.5641"
change_From_52_week_low="0.1356"
change_in_percent="-1.8077%"
close="0.7659"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.6470"
ebitda="-42.12M"
eps_estimate_current_year="-1.5500"
eps_estimate_next_quarter="-0.3100"
eps_estimate_next_year="-1.1800"
ex_dividend_date="N/A"
float_shares="15676000"
high="0.7900"
high_52_weeks="4.3300"
last_trade_date="1/20/2017"
last_trade_price="0.7659"
last_trade_size="10769"
last_trade_time="4:00pm"
low="0.7510"
low_52_weeks="0.6303"
market_capitalization="21.01M"
moving_average_200_day="1.2829"
moving_average_50_day="0.7806"
name="Cerulean Pharma Inc."
notes="N/A"
one_year_target_price="4.5000"
open="0.7900"
pe_ratio="N/A"
peg_ratio="0.0000"
percent_change_from_200_day_moving_average="-40.3003%"
percent_change_from_50_day_moving_average="-1.8801%"
percent_change_from_52_week_high="-82.3118%"
percent_change_from_52_week_low="+21.5136%"
previous_close="0.7800"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="1.2850"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="27435000"
short_ratio="2.8800"
stock_exchange="NGM"
symbol="CERU"
volume="185843"
weeks_range_52="0.6303 - 4.3300"
